Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Art of Waiting: Making COVID-19 Vaccine Rollouts More Efficient and Cutting Wait Times

The approval of several vaccines against the novel coronavirus is welcome news around the world. Now that there are vaccines proven to work, the struggle has become how to get those shots from labs to human bodies. It’s tough to consume news coverage and not see scenes of long lines of cars or people…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
The Art of Waiting: Making COVID-19 Vaccine Rollouts More Efficient and Cutting Wait Times

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The approval of several vaccines against the novel coronavirus is welcome news around the world. Now that there are vaccines proven to work, the struggle has become how to get those shots from labs to human bodies.

It’s tough to consume news coverage and not see scenes of long lines of cars or people at vaccine rollout sites as counties and states wrestle with the best way to begin protecting people in their communities.

Those lines may be preventable, said Erik Berg, VP of Marketing for NEMO-Q, and it starts with understanding exactly how many people a facility can handle and when they should be asked to join the queue.

“Where we come in is we provide lots of crucial KPIs so these facilities can be as efficient as possible,” Berg said. “Second, when it comes to vaccinating people and getting people tested, 60 seconds adds up to a minute, 60 minutes add up to an hour and so on. We really provide incredibly detailed service times, what you can expect and how long it will take to vaccinate people or test them, so we can get people in and out as quickly and efficiently as possible.”

Providers or government agencies may think their hands are tied by the price of a system like NEMO-Q’s, but the company is working to help stop the spread of COVID-19, as well, and has an affordable and easy-to-use solution for most vaccine providers.

“It is incredibly cost-effective and simple on the end of the healthcare provider,” Berg said. “They’re pretty much hands-off with the process. We know what they need at this point, so we’re looking to be as big of an ally as possible. The budget can stay low. Even some of our more cost-effective, simpler products can make a world of difference when it comes to getting these patients seen as quickly as possible,” Berg said. “We’re willing to work with all these healthcare facilities as best we can.”

With the company’s experience working with healthcare providers even before the pandemic started, solutions required now during the peak of the pandemic can be easily repurposed when the situation improves and things like flu shots, routine appointments, or aches and pains become the primary focus once again. With effective queuing solutions, that could happen even faster than expected.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Get  checked out

Get checked out

Seeking medical evaluation immediately after a vehicle crash, regardless of how you feel, is essential because adrenaline can mask serious injuries for hours or even up to a full day. A same-day medical visit creates a documented paper trail tied to the accident date, which protects against insurance companies disputing injury claims and denying compensation.

  • 01Feeling fine immediately after a vehicle crash may not accurately reflect one's health condition.
  • 02The body's response to stress can delay the onset of injury symptoms.
  • 03Seek medical evaluation after a crash, even if injuries aren't immediately apparent.

Sep 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512